Answers are grounded in this paper and cite their sources.
Analysis materials for the systematic review and exploratory meta-analysis: GLP-1 Receptor Agonists and Incident Dementia in Type 2 Diabetes (PROSPERO CRD420261520004). Contents: frozen estimate dataset (numbers-k8.csv; eight pooled observational estimates plus two extended k=9 inputs); R/metafor analysis scripts with console outputs (primary REML + Hartung-Knapp analysis, data-source subgroups, sensitivity and leave-one-out analyses, two extended k=9 analyses); risk-of-bias ratings for all 75 included reports (73 assessment units; rob-assessments.csv); frozen extraction workbook with data dictionary; Figure 2 rendering script; search and screening logs (3,344-record screening master, re-screening worklists, per-database search records). Data files: CC BY 4.0; code files: MIT.
No takes yet. Share an insight, caveat, or question.
He et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: